Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PhytoMedical Accelerates Development for Type 2 Diabetes Compound - Nutraceuticals World
Market Updates

PhytoMedical Accelerates Development for Type 2 Diabetes Compound

PhytoMedical Accelerates Development for Type 2 Diabetes Compound
PhytoMedical Technologies, Inc., Vancouver, British Columbia, has planned to increase its team of collaborating scientists developing a new cinnamon-derived compound for type 2 diabetes. The company plans to double the number of scientists working on this important diabetes research, from three full time scientists to six, in order to accelerate development. Through a three-way Cooperative Research and Development Agreement with the USDA’s Agricultural Research Service and Iowa State University, PhytoMedical’s team of collaborating scientists is working to synthesize several poly­phenolic compounds, originally isolated and characterized from cinnamon bark, which increase sugar metabolism by a factor of 20 in test tube assays using fat cells. These new compounds have been found to increase insulin sensitivity by activating key enzymes that stimulate insulin receptors, while inhibiting those enzymes that deactivate them, basically resulting in insulin being more efficiently used by the body.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters